Provident Financial Services (FRA:PQ3) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:PQ3 Provident Financial Services Inc FRA:PQ3
54 GF Score
Price €20.20
GF Value €15.77
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Provident Financial Services Research & Development?

Provident Financial Services FRA:PQ3 -0.98% 54 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:PQ3 with a GF Score™ of 54/100 and a GF Value™ of €15.77 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Provident Financial Services's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Provident Financial Services  (FRA:PQ3) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Provident Financial Services Research & Development Related Terms

Provident Financial Services Research & Development Historical Data

* Premium members only.

The historical data trend for Provident Financial Services's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Provident Financial Services Research & Development Chart

Provident Financial Services Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Provident Financial Services Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:PQ3
54GF Score
Provident Financial Services Inc FRA:PQ3
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Provident Financial Services Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Provident Financial Services (FRA:PQ3) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Provident Financial Services and its competitors.
Is Provident Financial Services' Research & Development too high?
Provident Financial Services' current Research & Development is €0.0 Mil. Overall, Provident Financial Services has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Provident Financial Services' Research & Development compare to SBCF and BANC?
Provident Financial Services' Research & Development of €0.0 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Provident Financial Services and its competitors. Provident Financial Services's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Provident Financial Services stock overvalued right now?
Based on GuruFocus' analysis, Provident Financial Services (FRA:PQ3) is currently considered Modestly Overvalued. The stock's GF Value™ is €15.77, compared to a current price of €20.20 — trading 28.1% above its estimated fair value. The current Research & Development is €0.0 Mil. Provident Financial Services' overall GF Score™ is 54/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Provident Financial Services (FRA:PQ3), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Provident Financial Services (FRA:PQ3) Overvalued in 2026?

Based on GuruFocus' analysis, Provident Financial Services stock appears to be overvalued. The current stock price of €20.20 is trading 28.1% above its estimated GF Value™ of €15.77. GuruFocus considers Provident Financial Services to be Modestly Overvalued.

Key valuation signals for FRA:PQ3:

  • Research & Development: €0.0 Mil
  • GF Value™: €15.77 vs. price of €20.20 (28.1% above fair value)
  • GF Score™: 54/100 with 8 warning signs

No single metric tells the full story. See the FRA:PQ3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Provident Financial Services Business Description

Other Exchanges PFS:USA
Address 239 Washington Street, Jersey, NJ, USA, 07302
Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income. These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.
54GF Score

Get the complete analysis for FRA:PQ3

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.20
Price
€15.77
GF Value